For the Inventor, By the Inventor

Enter assignee name

Cupertino, CA, United States of America

Galaxy Biotech, LLC

USPTO Granted Patents = 15

% Expired Patents = 40.0

CIPO Patents = 2

EPO Patents = 7

Forward Citations = 122

Loading Chart...

Loading Chart...

8 inventors (with patents filed for the assignee):

Kyung Jin Kim (15 out of 43 patents)

Maximiliano Vasquez (12 out of 69 patents)

Hangil Park (12 out of 15 patents)

4. Wei-meng Zhao (7 out of 7 patents)

5. Lihong Wang (5 out of 9 patents)

6. Yi-Chi Su (3 out of 3 patents)

7. April Zhang (2 out of 2 patents)

8. Yi Ding (2 out of 24 patents)

9. Yi Ding (1 patent)

10. Kim Kyung Jin (0 patent)

11. Wei-Meng Zhao (0 patent)

15 patents: Sort by Forward Citations

1. 12679897 - MONOCLONAL ANTIBODIES TO FIBROBLAST GROWTH FACTOR RECEPTOR 2 (2026-07-14),

2. 11891446 - Highly potent antibodies binding to death receptor 5 (2024-02-06),

3. 10941204 - Highly potent antibodies binding to death receptor 4 (2021-03-09),

4. 10689448 - Monoclonal antibodies to fibroblast growth factor receptor 2 (2020-06-23),

5. 10138301 - Monoclonal antibodies to fibroblast growth factor receptor 2 (2018-11-27),

6. 9834609 - Methods of detecting a tumor expressing fibroblast growth factor receptor 2 (2017-12-05),

7. 9382324 - Monoclonal antibodies to fibroblast growth factor receptor 2 (2016-07-05),

8. 8628778 - Humanized monoclonal antibodies to hepatocyte growth factor (2014-01-14),

9. 8603987 - Monoclonal antibodies to fibroblast growth factor receptor 2 (2013-12-10),

10. 8101725 - Monoclonal antibodies to basic fibroblast growth factor (2012-01-24),

11. 8101723 - Monoclonal antibodies to fibroblast growth factor receptor 2 (2012-01-24),

12. 7687063 - Treating solid tumors with an antibody to hepatocyte growth factor (2010-03-30),

13. 7632926 - Humanized monoclonal antibodies to hepatocyte growth factor (2009-12-15),

14. 7494650 - Monoclonal antibodies to hepatocyte growth factor (2009-02-24),

15. 7220410 - Monoclonal antibodies to hepatocyte growth factor (2007-05-22),

Galaxy Biotech, LLC is a pioneering biotechnology company specialized in developing innovative therapeutic solutions. With a focus on cutting-edge research and development, we strive to improve the quality of life for patients worldwide. Our team of experienced scientists and experts work tirelessly to discover breakthrough treatments, utilizing advanced technologies and methodologies. We are driven by a passion for scientific excellence and a commitment to addressing unmet medical needs. Visit our website to learn more about our exciting projects and potential career opportunities in the field of biotechnology.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

15 Patents

#52 in Cupertino, CA

#5,018 in California

#21,010 in US

#39,795 in the World

Cupertino, CA, United States of America

Galaxy Biotech, LLC

Forward Citations = 122

8 inventors:

Kyung Jin Kim (15 out of 43 patents)

Maximiliano Vasquez (12 out of 69 patents)

Hangil Park (12 out of 15 patents)

4. Wei-meng Zhao (7 out of 7 patents)

5. Lihong Wang (5 out of 9 patents)

Please report any incorrect information to [email protected]

Loading…